Literature DB >> 11112882

Allergic and immunologic disorders of the eye. Part II: ocular allergy.

L Bielory1.   

Abstract

Allergy affects more than 15% of the world population, and some studies have shown that up 30% of the US population has some form of allergy. Most of these patients have various target organs for their allergies, and most have ocular involvement. The ocular component may be the most prominent and sometimes disabling feature of their allergy. Some are affected for only a few weeks to months, whereas others have symptoms that last throughout the year. The seasonal forms may present to clinical allergists, whereas the more chronic forms may present to ophthalmologists. Thus, in the second of this 2-part review series (Part I: Ocular Immunology appeared in the November issue of the Journal), an overview is provided of the spectrum of ocular allergy that ranges from acute seasonal allergic conjunctivitis to chronic variants of atopic keratoconjunctivitis. With a better understanding of the immunologic mechanisms, we now can develop better treatment approaches and design further research in intervention of allergic eye diseases.

Entities:  

Mesh:

Year:  2000        PMID: 11112882     DOI: 10.1067/mai.2000.111238

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  48 in total

Review 1.  Overview of ocular allergy treatment.

Authors:  M Friedlaender
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

2.  Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitis.

Authors:  Heikki Peuravuori; Osmo Kari; Sirje Peltonen; Valtteri V Aho; Jukka M Saari; Yrjö Collan; Marko Määttä; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-26       Impact factor: 3.117

Review 3.  [Pathophysiology of atopic blepharokeratoconjunctivitis].

Authors:  T Lapp; P Maier; T Jakob; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

4.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

5.  Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy.

Authors:  Z Pelikan
Journal:  Eye (Lond)       Date:  2014-01-17       Impact factor: 3.775

6.  Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies.

Authors:  Arthur B Epstein; Peter T Van Hoven; Alan Kaufman; Warner W Carr
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Conjunctivitis and Total IgE in Lacrimal Fluid: Lacrytest Screening.

Authors:  Susana Monzón; Elena Arrondo; Joan Bartra; Ferran Torres; María Basagaña; M Del Mar San Miguel; Rosario Alonso; Anna Cisteró-Bahima
Journal:  J Allergy (Cairo)       Date:  2009-04-12

Review 8.  Ocular allergy guidelines: a practical treatment algorithm.

Authors:  Leonard Bielory
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 9.  Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

Review 10.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.